Literature DB >> 28697032

Genicular Radiofrequency Ablation for Treatment of Post Total Knee Arthroplasty Posterior Thigh Pain: A Case Report.

Lauren N Sylvester1, Johnathan H Goree.   

Abstract

We present a case of a 68-year-old woman with 6 months of chronic unilateral posterior thigh pain after a total knee arthroplasty. The patient's pain was refractory to various treatments. After appropriate diagnostic tests, a genicular nerve block and subsequent radiofrequency ablation were performed. These procedures provided substantial pain relief of her thigh pain at 3 months follow-up.

Entities:  

Mesh：

Year:  2017        PMID： 28697032     DOI： 10.1213/XAA.0000000000000596

Source DB:  PubMed          Journal:  A A Case Rep        ISSN： 2325-7237


  5 in total

Review 1.  Management of Refractory Pain After Total Joint Replacement.

Authors:  Max L Willinger; Jamie Heimroth; Nipun Sodhi; Luke J Garbarino; Peter A Gold; Vijay Rasquinha; Jonathan R Danoff; Sreevathsa Boraiah
Journal:  Curr Pain Headache Rep       Date:  2021-04-17

2.  A guide to regional analgesia for Total Knee Arthroplasty.

Authors:  Fabio A Rodriguez-Patarroyo; Nadin Cuello; Robert Molloy; Viktor Krebs; Alparslan Turan; Nicholas S Piuzzi
Journal:  EFORT Open Rev       Date:  2021-12-10

3.  Periarticular needle-based therapies can cause periprosthetic knee infections.

Authors:  Patrick W Moody; Thomas K Fehring; Bryan D Springer
Journal:  Arthroplast Today       Date:  2020-03-21

Review 4.  Safety and Efficacy of Genicular Nerve Radiofrequency Ablation for Management of Painful Total Knee Replacement: A Systematic Review.

Authors:  Naga Cheppalli; Amit W Bhandarkar; Senthil Sambandham; Solomon F Oloyede
Journal:  Cureus       Date:  2021-11-11

Review 5.  Efficacy and Safety of Ultrasound-Guided Radiofrequency Treatment for Chronic Pain in Patients with Knee Osteoarthritis: A Systematic Review and Meta-Analysis.

Authors:  Yuzhao Huang; Qiufang Deng; Liuqing Yang; Jiahui Ma; Ziyang Wang; Dong Huang; Ling Luo; Haocheng Zhou
Journal:  Pain Res Manag       Date:  2020-09-19       Impact factor: 3.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.